Injectable healing protocol: Dose: 2-3mg daily (higher end of range) Frequency: Daily throughout healing period Duration: Until wound resolves plus 1-2 weeks Injection site: Systemic (not into wound) Topical healing protocol: Concentration: 2-4% in wound-appropriate vehicle Application: 2-3 times daily to wound margins (not directly into open wounds) Duration: Throughout healing process Note: Consult healthcare provider for significant wounds GHK-CU pairs exceptionally well with BPC-157 and TB-500 for wound healing
albicans possesses the transcription factor Sfu1 that inhibits iron uptake, various transcription factors that control iron permeability (such as plasma membrane-related Ftr1 and Ftr2 and vacuole-related Fth1 and Fth2) [34,35,36], and a variety of iron oxidases [36,37,38,39]
It requires neurotrophic support, reduced inflammation, and sufficient neural substrate, meaning enough surviving and newly generated neurons to form the new pathways needed for functional recovery
When the liver accumulates excess fat, the "exhaust" increases